- Home
- BCTX vs NA Comparison
BCTX vs NA Comparison
Compare BCTX & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- NA
- Stock Information
- Founded
- BCTX 2014
- NA 2019
- Country
- BCTX Canada
- NA China
- Employees
- BCTX N/A
- NA N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- NA Semiconductors
- Sector
- BCTX Health Care
- NA Technology
- Exchange
- BCTX Nasdaq
- NA Nasdaq
- Market Cap
- BCTX 34.6M
- NA 32.3M
- IPO Year
- BCTX N/A
- NA 2022
- Fundamental
- Price
- BCTX $0.56
- NA $8.72
- Analyst Decision
- BCTX Strong Buy
- NA
- Analyst Count
- BCTX 1
- NA 0
- Target Price
- BCTX $15.00
- NA N/A
- AVG Volume (30 Days)
- BCTX 2.4M
- NA 238.6K
- Earning Date
- BCTX 12-16-2024
- NA 09-18-2024
- Dividend Yield
- BCTX N/A
- NA N/A
- EPS Growth
- BCTX N/A
- NA N/A
- EPS
- BCTX N/A
- NA N/A
- Revenue
- BCTX N/A
- NA $6,991,446.00
- Revenue This Year
- BCTX N/A
- NA N/A
- Revenue Next Year
- BCTX N/A
- NA N/A
- P/E Ratio
- BCTX N/A
- NA N/A
- Revenue Growth
- BCTX N/A
- NA N/A
- 52 Week Low
- BCTX $0.46
- NA $2.75
- 52 Week High
- BCTX $5.97
- NA $47.50
- Technical
- Relative Strength Index (RSI)
- BCTX 38.43
- NA 52.33
- Support Level
- BCTX $0.57
- NA $6.67
- Resistance Level
- BCTX $0.66
- NA $10.42
- Average True Range (ATR)
- BCTX 0.13
- NA 1.68
- MACD
- BCTX -0.05
- NA -0.21
- Stochastic Oscillator
- BCTX 0.00
- NA 28.51
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.